2nd Annual Summa Health Epilepsy Symposium
Topic: Epilepsy Biomarkers & Precision Medicine Through the Lifespan
Dive Deeper into Epilepsy: Biomarkers & Precision Medicine
On May 2, 2024, our esteemed neurology team and colleagues provided an insightful exploration of epilepsy biomarkers and precision medicine, and their transformative impact on patient care.
Medical advancements are revolutionizing the way we diagnose and treat epilepsy, a condition affecting millions. In the U.S. alone, over 3.4 million people, or 1 in 26, will be diagnosed with epilepsy, making it the fourth most common neurological disease.
This event provided:
- In-depth knowledge: Explore the different types of epilepsy biomarkers, including electrophysiological, neuroimaging, behavioral, and genetic markers, and their detection throughout a patient's life.
- Precision therapy insights: Learn how biomarker analysis aids in the development of personalized and effective treatment strategies.
- From bench to bedside: Discover the exciting roadmap showcasing how animal models pave the way for the development of targeted therapies in humans.